OBJECTIVE ：To investigate the application status of oral hypoglycemic drugs in outpatient pharmacy of the First Affiliated Hospital of Henan University （hereinafter referred to as ＂ our hospital＂） during 2013-2016. METHODS： Consumption sum ranking and defined daily dose system （DDDs） methods were adopted, statistical analysis was conducted on the application data of oral hypoglycemic drugs in terms of categories, consumption sum, DDDs and defined daily cost （ DDC）, ect. RESULTS ： The consumption sum of differet~t kinds of oral hypoglycemic drugs were stable during 2013-2016, among which the consumption sum of a-glucosidase inhibitor and sulfonylurea accounted almost 1/3. For four years, the medication frequence ranking of metformin took the lead. The medication frequence of gliclazide were in an increasing trend, the ranking of which dominated the second place and over acarbose in 2015. The consumption amount of glinides andnew antidiabetic drugs of DPP-4 were small, and TZDS drugs was the least. CONCLUSIONS ： Metformin, gliclazide and acarbose play the leading role in outpatients of our hospital, and the selection of propensity in diabetics are larger, which is conform to Guide to Chinese Type 2 Diabetes （2013）. Meanwhile, glinides and new antidiabetic drugs of DPP-4 are not widely applied.
Evaluation and Analysis of Drug-use in Hospitals of China